retatrutide medication vs CagriSema: The Battle Nobody's Covering Retatrutide: The New Triple-Agonist Weight

Whilst no medications are currently licensed specifically for fatty liver disease in the UK, GLP-1 receptor agonistsoriginally developed for type 2 diabetesshow promising benefits for liver health

A new Medicare initiative may soon help make these medications more accessible

High Cost-Sharing: Even with coverage, these drugs will likely be placed on the highest formulary tiers

Its important to note that the benefits of using GLP-1 medications may vary, depending on the individual using them and the drug dosage

Heres what to keep in mind: Are CGMs accurate

For those considering B12 injections for wellness purposes, such as energy enhancement, its important to note that the benefits are less well established